Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;83:241-251

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yee, K. O
Right arrow Articles by Schwartz, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yee, K. O
Right arrow Articles by Schwartz, S. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOHEXIMIDE
(Circulation Research. 1998;83:241-251.)
© 1998 American Heart Association, Inc.


Original Contribution

Role of ß1 and ß3 Integrins in Human Smooth Muscle Cell Adhesion to and Contraction of Fibrin Clots In Vitro

Karen O Yee, Michael M. Rooney, Cecilia M. Giachelli, Susan T. Lord, , Stephen M. Schwartz

From the Departments of Pathology (K.O.Y., C.M.G., S.M.S.) and Molecular and Cellular Biology (K.O.Y.), University of Washington, Seattle, and Departments of Chemistry (M.M.R., S.T.L.) and Pathology and Laboratory Medicine (S.T.L.), University of North Carolina at Chapel Hill.

Correspondence to Karen O Yee, University of Washington, Box 357335, Seattle, WA 98195. E-mail y66409d{at}u.washington.edu

Abstract—The degree of lumen narrowing in advanced lesions correlates poorly with the amount of intimal mass accumulated in the atherosclerotic plaque. As an alternate mechanism of stenosis, we propose that human smooth muscle cells bind to fibrin deposited in the matrix and exert contractile forces to cause a narrowing of the lumen. In the present study we demonstrated in vitro that human newborn aortic smooth muscle cell lines can contract and adhere to fibrin clots composed of either fibronectin-depleted plasma ("plasma") or recombinant fibrin. By using neutralizing antibodies and RGD peptides, we showed that members of the integrin family mediated the interaction between human newborn smooth muscle cells and fibrin. Neutralizing antibodies against the integrin {alpha}vß3 (c7E3 Fab and LM609) did not inhibit either plasma clot contraction or recombinant fibrin clot contraction by human newborn smooth muscle cells. In contrast, antibodies against {alpha}5, ß1, and {alpha}5ß1 inhibited contraction of clots composed of either plasma or recombinant fibrin. Anti-{alpha}vß3, anti-{alpha}v, anti-{alpha}5, anti-ß1, and anti-{alpha}5ß1 antibodies inhibited human newborn smooth muscle cell adhesion to plasma clots; however, only anti-{alpha}5, anti-ß1, and anti-{alpha}5ß1 antibodies significantly inhibited adhesion to recombinant fibrin. While the linear RGD peptides had no effect, the cyclic peptide penRGD inhibited adhesion to plasma clots and recombinant fibrin. However, it did not block contraction of recombinant fibrin clots. These results suggest that during the interaction of human newborn smooth muscle cell lines with fibrin, {alpha}5ß1 plays a significant role. This interaction is of potential interest as a target for efforts to block vascular contraction.


Key Words: atherosclerosis • remodeling • stenosis • thrombosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
Z. Sun, L. A. Martinez-Lemus, M. A. Hill, and G. A. Meininger
Extracellular matrix-specific focal adhesions in vascular smooth muscle produce mechanically active adhesion sites
Am J Physiol Cell Physiol, July 1, 2008; 295(1): C268 - C278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Cho, J. L. Degen, B. S. Coller, and D. F. Mosher
Fibrin but Not Adsorbed Fibrinogen Supports Fibronectin Assembly by Spread Platelets: EFFECTS OF THE INTERACTION OF {alpha}IIb{beta}3 WITH THE C TERMINUS OF THE FIBRINOGEN {gamma}-CHAIN
J. Biol. Chem., October 21, 2005; 280(42): 35490 - 35498.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. P. Podolnikova, V. P. Yakubenko, G. L. Volkov, E. F. Plow, and T. P. Ugarova
Identification of a Novel Binding Site for Platelet Integrins {alpha}IIb{beta}3 (GPIIbIIIa) and {alpha}5{beta}1 in the {gamma}C-domain of Fibrinogen
J. Biol. Chem., August 22, 2003; 278(34): 32251 - 32258.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. P. Moiseeva
Adhesion receptors of vascular smooth muscle cells and their functions
Cardiovasc Res, December 1, 2001; 52(3): 372 - 386.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. L. Davenpeck, C. Marcinkiewicz, D. Wang, R. Niculescu, Y. Shi, J. L. Martin, and A. Zalewski
Regional Differences in Integrin Expression : Role of {{alpha}}5{beta}1 in Regulating Smooth Muscle Cell Functions
Circ. Res., February 16, 2001; 88(3): 352 - 358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ikari, K. Fujikawa, K. O. Yee, and S. M. Schwartz
alpha 1-Proteinase Inhibitor, alpha 1-Antichymotrypsin, or alpha 2-Macroglobulin Is Required for Vascular Smooth Muscle Cell Spreading in Three-dimensional Fibrin Gel
J. Biol. Chem., April 21, 2000; 275(17): 12799 - 12805.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E Stringa, V Knauper, G Murphy, and J Gavrilovic
Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells
J. Cell Sci., January 6, 2000; 113(11): 2055 - 2064.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Corbett and J. E. Schwarzbauer
Requirements for alpha 5beta 1 Integrin-mediated Retraction of Fibronectin-Fibrin Matrices
J. Biol. Chem., July 23, 1999; 274(30): 20943 - 20948.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. R. Coleman, G. A. Braden, M. C. Willingham, and D. C. Sane
Vitaxin, a Humanized Monoclonal Antibody to the Vitronectin Receptor ({alpha}vß3), Reduces Neointimal Hyperplasia and Total Vessel Area After Balloon Injury in Hypercholesterolemic Rabbits
Circ. Res., June 11, 1999; 84(11): 1268 - 1276.
[Abstract] [Full Text] [PDF]